Form C-AR - Annual Report:
SEC Accession No. 0001822782-26-000003
Filing Date
2026-05-06
Accepted
2026-05-06 12:47:53
Documents
2
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 3665
2 form_car.pdf EX-99 1768565
  Complete submission text file 0001822782-26-000003.txt   2440162
Mailing Address 2033 6TH AVE SUITE 600 SUITE 300 SEATTLE WA 28121
Business Address 1600 FAIRVIEW AVENUE EAST SUITE 300 SEATTLE WA 98102 2144788208
Deverra Therapeutics, Inc. (Filer) CIK: 0001822782 (see all company filings)

EIN.: 843312665 | State of Incorp.: DE
Type: C-AR | Act: 33 | File No.: 020-33895 | Film No.: 26947249